Welcome to LookChem.com Sign In|Join Free

CAS

  • or

180160-47-8

Post Buying Request

180160-47-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

180160-47-8 Usage

Uses

Different sources of media describe the Uses of 180160-47-8 differently. You can refer to the following data:
1. 5-Chlorospiro[isobenzofuran-1(3H),4'-piperidin]-3-one is a (spiro)(hetero)cyclic amides as modulator of 11-β hydroxysteroid dehydrogenase type 1.
2. 5-Chlorospiro[isobenzofuran-1(3H),4''-piperidin]-3-one is a (spiro)(hetero)cyclic amides as modulator of 11-β hydroxysteroid dehydrogenase type 1.

Check Digit Verification of cas no

The CAS Registry Mumber 180160-47-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,0,1,6 and 0 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 180160-47:
(8*1)+(7*8)+(6*0)+(5*1)+(4*6)+(3*0)+(2*4)+(1*7)=108
108 % 10 = 8
So 180160-47-8 is a valid CAS Registry Number.

180160-47-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-chlorospiro[2-benzofuran-3,4'-piperidine]-1-one

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:180160-47-8 SDS

180160-47-8Upstream product

180160-47-8Downstream Products

180160-47-8Relevant articles and documents

CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF

-

Paragraph 1472; 1473; 1474; 1338; 1339; 1340, (2016/02/21)

Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: or physiologically acceptable salt thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 180160-47-8